Clinical trials: Hemodialysis-Induced Symptom, open to volunteers
Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD)
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients
Sarcopenia, abbreviated as muscle loss, is a prevalent complication among patients with chronic kidney disease (CKD), particularly those with end - stage renal disease (ESRD). It significantly impacts patients' quality of life.
- Conditions
- Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD), Dialysis Patients
- Trial name
- HIF-PHI (NCT07162090)
- Testing
- Roxadustat, Recombinant human erythropoietin (EPO)
- Volunteers
- 60 people
- Sponsor
- Tianjin Medical University General Hospital
Fluid Overload, Dialysis; Complications
ULtrafiltration-Rate Induced CArdiac Strain (ULRICA) - Study
Patients performing chronic hemodialysis (HD) retain more or less water between dialyses. The water is removed by ultrafiltration and usually during the cleansing of waste products - the HD.
- Trial name
- ULRICA (NCT06153888)
- Testing
- Ultrafiltration rate
- Where
- Sweden
- Volunteers
- 40 people
- Sponsor
- Umeå University